000 02465 a2200733 4500
005 20250518043840.0
264 0 _c20201207
008 202012s 0 0 eng d
022 _a1600-0641
024 7 _a10.1016/j.jhep.2019.05.028
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBorgia, Sergio M
245 0 0 _aSofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis.
_h[electronic resource]
260 _bJournal of hepatology
_c10 2019
300 _a660-665 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAntiviral Agents
_xadministration & dosage
650 0 4 _aCarbamates
_xadministration & dosage
650 0 4 _aDrug Combinations
650 0 4 _aDrug Monitoring
_xmethods
650 0 4 _aFemale
650 0 4 _aHepacivirus
_xgenetics
650 0 4 _aHepatitis C, Chronic
_xcomplications
650 0 4 _aHeterocyclic Compounds, 4 or More Rings
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xcomplications
650 0 4 _aLiver Cirrhosis
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRenal Dialysis
_xmethods
650 0 4 _aSofosbuvir
_xadministration & dosage
650 0 4 _aSustained Virologic Response
650 0 4 _aTreatment Outcome
700 1 _aDearden, Janet
700 1 _aYoshida, Eric M
700 1 _aShafran, Stephen D
700 1 _aBrown, Ashley
700 1 _aBen-Ari, Ziv
700 1 _aCramp, Matthew E
700 1 _aCooper, Curtis
700 1 _aFoxton, Matthew
700 1 _aRodriguez, Conrado Fernandez
700 1 _aEsteban, Rafael
700 1 _aHyland, Robert
700 1 _aLu, Sophia
700 1 _aKirby, Brian J
700 1 _aMeng, Amy
700 1 _aMarkova, Svetlana
700 1 _aDvory-Sobol, Hadas
700 1 _aOsinusi, Anu O
700 1 _aBruck, Rafael
700 1 _aAmpuero, Javier
700 1 _aRyder, Stephen D
700 1 _aAgarwal, Kosh
700 1 _aFox, Raymond
700 1 _aShaw, David
700 1 _aHaider, Shariq
700 1 _aWillems, Bernard
700 1 _aLurie, Yoav
700 1 _aCalleja, Jose Luis
700 1 _aGane, Edward J
773 0 _tJournal of hepatology
_gvol. 71
_gno. 4
_gp. 660-665
856 4 0 _uhttps://doi.org/10.1016/j.jhep.2019.05.028
_zAvailable from publisher's website
999 _c29794373
_d29794373